Rite Aid and other US pharmacies could soon sell a drug derived from cannabis.
The Food and Drug Administration on June 25 approved Epidiolex, a treatment for epilepsy created by British drugmaker GW Pharmaceuticals (GWPH).
The Drug Enforcement Administration has 90 days to schedule the medication, and it is widely expected to allow doctors to prescribe it. That will open the cannabis industry to mainstream pharmacies and medical practitioners.
Rite Aid (RAD) told CNNMoney it would sell Epidiolex once the DEA schedules it. “Rite Aid pharmacists fill prescriptions in accordance with all state regulations and laws as well as those set forth by the DEA and FDA,” said Rite Aid spokeswoman Ashley Flower. “Given that Epidiolex has received approval from the FDA, upon being rescheduled, Rite Aid expects to fill prescriptions for Epidiolex later this year based on availability.”
To read more visit CNN Money